Testing behaviour and positivity for SARS-CoV-2 infection: insights from web-based participatory surveillance in the Netherlands.
Testing behaviour and positivity for SARS-CoV-2 infection: insights from web-based participatory surveillance in the Netherlands.
复制标题
DOI:
10.1136/bmjopen-2021-056077
复制
发表时间:
2021-12-21
期刊:
影响因子:
2.9
通讯作者:
van Hoek AJ
中科院分区:
文献类型:
--
作者:
McDonald SA;Soetens LC;Schipper CMA;Friesema I;van den Wijngaard CC;Teirlinck A;Neppelenbroek N;van den Hof S;Wallinga J;van Hoek AJ
We aimed to identify populations at a high risk for SARS-CoV-2 infection but who are less likely to present for testing, by determining which sociodemographic and household factors are associated with a lower propensity to be tested and, if tested, with a higher risk of a positive test result. Internet-based participatory surveillance data from the general population of the Netherlands. Weekly survey data collected over a 5-month period (17 November 2020 to 18 April 2021) from a total of 12 026 participants who had contributed at least 2 weekly surveys was analysed. Multivariable analyses using generalised estimating equations for binomial outcomes were conducted to estimate the adjusted ORs of testing and of test positivity associated with participant and household characteristics. Male sex (adjusted OR for testing (ORt): 0.92; adjusted OR for positivity (ORp): 1.30, age groups<20 (ORt: 0.89; ORp: 1.27), 50–64 years (ORt: 0.94; ORp: 1.06) and 65+ years (ORt: 0.78; ORp: 1.24), diabetics (ORt: 0.97; ORp: 1.06) and sales/administrative employees (ORt: 0.93; ORp: 1.90) were distinguished as lower test propensity/higher test positivity factors. The factors identified using this approach can help identify potential target groups for improving communication and encouraging testing among those with symptoms, and thus increase the effectiveness of testing, which is essential for the response to the COVID-19 pandemic and for public health strategies in the longer term.
登录
查看更多内容
影响因子:
3.8
作者:
van Noort, Sander P.;Codeco, Claudia T.;Gomes, M. Gabriela M.
通讯作者:
Gomes, M. Gabriela M.
影响因子:
29.9
作者:
Aleta A;Martín-Corral D;Pastore Y Piontti A;Ajelli M;Litvinova M;Chinazzi M;Dean NE;Halloran ME;Longini IM Jr;Merler S;Pentland A;Vespignani A;Moro E;Moreno Y
通讯作者:
Moreno Y
影响因子:
5.5
作者:
Lieberman-Cribbin, Wil;Tuminello, Stephanie;Taioli, Emanuela
通讯作者:
Taioli, Emanuela
影响因子:
29.9
作者:
Allen WE;Altae-Tran H;Briggs J;Jin X;McGee G;Shi A;Raghavan R;Kamariza M;Nova N;Pereta A;Danford C;Kamel A;Gothe P;Milam E;Aurambault J;Primke T;Li W;Inkenbrandt J;Huynh T;Chen E;Lee C;Croatto M;Bentley H;Lu W;Murray R;Travassos M;Coull BA;Openshaw J;Greene CS;Shalem O;King G;Probasco R;Cheng DR;Silbermann B;Zhang F;Lin X
通讯作者:
Lin X
DOI:
10.2807/1560-7917.es.2018.23.25.1700337
发表时间:
2018-06
期刊:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
影响因子:
--
作者:
Guerrisi C;Turbelin C;Souty C;Poletto C;Blanchon T;Hanslik T;Bonmarin I;Levy-Bruhl D;Colizza V
通讯作者:
Colizza V